WHO ICTRP trial
Quantitative FDG-PET/CT of primary bladder cancer
NL-OMON33365 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON33365 |
|---|---|
| Public title | Quantitative FDG-PET/CT of primary bladder cancer |
| Scientific title | Quantitative FDG-PET/CT of primary bladder cancer - Quantitative FDG-PET/CT of primary bladder cancer |
| Primary sponsor | Antoni van Leeuwenhoek Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Bladder cancer bladder carcinoma;10038364;10004994;Bladder cancer;bladder carcinoma |
| Interventions | ;Bladder cancer;Bladder catheter;FDG-PET/CT |
| Registration date | Jan 13, 2010 |
| Target size | 10 |
| Secondary IDs | NL27877.031.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: